344. 極長鎖アシル-CoA 脱水素酵素欠損症 Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 6 / 薬物数 : 10 - (DrugBank : 2) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 10
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Bezafibrate
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark
Exercise
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States
Ketone ester drink
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Magnetic resonance imaging
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Muscle biopsy
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Nutritional ketone supplement
Oregon Health and Science University
2022 Early Phase 1 NCT05411835 United States
UX007
Ultragenyx Pharmaceutical Inc
2014 Phase 2 NCT02214160 United Kingdom;United States
2014 Phase 2 NCT01886378 United Kingdom;United States
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark
Exercise
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States
Ketone ester drink
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Magnetic resonance imaging
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Muscle biopsy
University Medical Center Groningen
2016 - NCT03531554 Netherlands
Nutritional ketone supplement
Oregon Health and Science University
2022 Early Phase 1 NCT05411835 United States
UX007
Ultragenyx Pharmaceutical Inc
2014 Phase 2 NCT02214160 United Kingdom;United States
2014 Phase 2 NCT01886378 United Kingdom;United States